Search Results 531-540 of 12306 for scad
Contact the Translational Nanomedicine Program at Mayo Clinic about our research on novel nanotechnologies to improve cancer diagnosis and treatment.
About this study. This proposal is for a pilot study comparing volumes of 18F-DOPA-PET avidity with contrast enhancement and T2 FLAIR on MRI.
Dr. Halena Gazelka 01:00. Welcome, everyone to Mayo Clinic Q&A. I'm Dr. Halena Gazelka. We're recording this podcast on Monday, August the 9th, 2021.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
This is a multicenter, randomized, double-blind, placebo-controlled trial involving subjects with NASH cirrhosis and severe portal hypertension (defined as HVPG ...
This study will obtain additional information on participants – in particular PHQ9 depression scores and medication use during their enrollment in the MEVOKED ...
The study will also determine graft health (corneal endothelial cell loss) and survival through 5 years after DMEK, and factors associated with these outcomes, ...
Ponatinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...
The primary objective of this study is to determine whether transendocardial delivery of allogeneic human bone marrow-derived MPCs (rexlemestrocel-L) is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.